Drug:
Reaction: INFLUENZA
20260101 - 20261231
No. 501 - 600
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 501 | 26472658 |
US |
56 | 2 |
Discomfort, Illness, Pain, Influenza, Colitis, Disturbance in attention, Device issue, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 502 | 26472723 |
US |
64 | 2 |
Arrhythmia, Atrial fibrillation, Pneumonia, Dizziness, Influenza, Condition aggravated, Bronchitis, |
||||
ABALOPARATIDE, OSELTAMIVIR PHOSPHATE, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, TIRZEPATIDE, OXYBUTYNIN CHLORIDE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, CYANOCOBALAMIN, TORSEMIDE, |
||||
| 503 | 26473198 |
US |
26 | |
Influenza, Sleep disorder, Loss of personal independence in daily activities, Social problem, |
||||
CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, FLUOXETINE HYDROCHLORIDE, |
||||
| 504 | 26473236 |
CO |
2 | |
Multiple sclerosis relapse, Movement disorder, Arthralgia, Malaise, Urinary tract infection, Asthenia, Mobility decreased, Influenza, |
||||
OFATUMUMAB, OFATUMUMAB, OFATUMUMAB, OFATUMUMAB, |
||||
| 505 | 26473479 |
CA |
71 | 2 |
Pneumonia, Influenza, Illness, |
||||
BENRALIZUMAB, BENRALIZUMAB, PREDNISONE, ALBUTEROL SULFATE, ALBUTEROL, TIOTROPIUM BROMIDE INHALATION SPRAY, MONTELUKAST SODIUM, |
||||
| 506 | 26473657 |
2 | ||
Influenza, |
||||
RIBOCICLIB, |
||||
| 507 | 26473685 |
US |
0 | 2 |
Product preparation issue, Off label use, Seizure, Influenza, |
||||
STIRIPENTOL, STIRIPENTOL, STIRIPENTOL, STIRIPENTOL, STIRIPENTOL, STIRIPENTOL, STIRIPENTOL, STIRIPENTOL, STIRIPENTOL, STIRIPENTOL, CLOBAZAM, CLOBAZAM, LEVETIRACETAM, LEVETIRACETAM, |
||||
| 508 | 26473893 |
2 | ||
Pyrexia, Neutropenia, Influenza, |
||||
PEGFILGRASTIM-APGF, |
||||
| 509 | 26473963 |
US |
64 | 2 |
Stress cardiomyopathy, COVID-19, Influenza, |
||||
MAVACAMTEN, METOPROLOL TARTRATE, METOPROLOL, |
||||
| 510 | 26473971 |
EU |
79 | 1 |
Abdominal infection, Dehydration, Cardiovascular disorder, Splenic infarction, Intestinal perforation, Sepsis, Influenza, Acute kidney injury, Pneumonia, Gastrointestinal disorder, Essential hypertension, Hyperlactacidaemia, Mesenteric artery stenosis, Colitis, Metabolic acidosis, Fascial rupture, Enteritis, Gastrointestinal hypomotility, Colectomy, Asthenia, |
||||
SEMAGLUTIDE, GABAPENTIN, AMLODIPINE BESYLATE, |
||||
| 511 | 26474006 |
|||
Influenza, |
||||
CERTOLIZUMAB PEGOL, NAPROXEN, NAPROXEN SODIUM, FOLIC ACID, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, ERGOCALCIFEROL, METHOTREXATE, METHOTREXATE SODIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 512 | 26474229 |
US |
||
Influenza, |
||||
ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR, TOBRAMYCIN, |
||||
| 513 | 26474232 |
US |
2 | |
Influenza, Product dose omission issue, |
||||
TROFINETIDE, |
||||
| 514 | 26474301 |
PE |
63 | 2 |
Hypoacusis, Decreased immune responsiveness, Discouragement, Dysuria, Pain, Urticaria, Gait disturbance, Erythema, Diarrhoea, Malaise, Arthralgia, Headache, Epistaxis, Cough, Bone pain, Feeling abnormal, Influenza, Nasopharyngitis, |
||||
FULVESTRANT, RIBOCICLIB, |
||||
| 515 | 26474647 |
US |
47 | 1 |
Bronchitis, Influenza, Onychomadesis, Palmar-plantar erythrodysaesthesia syndrome, |
||||
TALQUETAMAB, |
||||
| 516 | 26475308 |
GB |
1 | |
Coronary artery disease, Influenza, Cardiac ventricular thrombosis, |
||||
INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, |
||||
| 517 | 26470802 |
US |
80 | 1 |
Influenza, Bronchitis, Illness, Feeding disorder, Gastrooesophageal reflux disease, Nausea, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 518 | 26470875 |
41 | ||
Influenza, Illness, Product dose omission issue, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 519 | 26471058 |
CA |
68 | 2 |
Pneumonia, Influenza, |
||||
GOLIMUMAB, |
||||
| 520 | 26471149 |
US |
34 | 1 |
Surgery, Norovirus infection, Influenza, Intentional dose omission, Product administration interrupted, |
||||
CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, OLMESARTAN MEDOXOMIL, SODIUM OXYBATE, |
||||
| 521 | 26469983 |
|||
Psoriasis, Influenza, Inappropriate schedule of product administration, |
||||
BIMEKIZUMAB, |
||||
| 522 | 26470016 |
CA |
2 | |
Ovarian cancer, Hepatic cancer, Abdominal pain upper, Full blood count decreased, Product dose omission issue, Immune system disorder, Bone pain, Fatigue, Influenza, White blood cell count decreased, Myalgia, Arthritis, |
||||
OLAPARIB, OLAPARIB, NAPROXEN, NAPROXEN SODIUM, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, |
||||
| 523 | 26470123 |
32 | ||
Rhinorrhoea, Influenza, Respiratory syncytial virus infection, Peripheral swelling, Product dose omission issue, |
||||
BIMEKIZUMAB, |
||||
| 524 | 26470153 |
CA |
73 | |
Type 2 diabetes mellitus, Weight increased, Influenza, Inappropriate schedule of product administration, Off label use, Product dose omission issue, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, CANDESARTAN, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, PAROXETINE, PAROXETINE HYDROCHLORIDE, PANTOPRAZOLE, FOLIC ACID, AMLODIPINE, DESONIDE, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 400, INSTALAX POLYETHYLENE GLYCOL 3350, METRONIDAZOLE, |
||||
| 525 | 26470236 |
|||
Hidradenitis, Condition aggravated, COVID-19, Influenza, Gastroenteritis viral, |
||||
BIMEKIZUMAB, |
||||
| 526 | 26470429 |
36 | ||
Influenza, Sinusitis, Musculoskeletal stiffness, Product dose omission issue, Maternal exposure during breast feeding, |
||||
BIMEKIZUMAB, |
||||
| 527 | 26473342 |
11 | 1 | |
Suicide attempt, Pyrexia, Influenza, Fear, |
||||
OSELTAMIVIR, OSELTAMIVIR PHOSPHATE, |
||||
| 528 | 26465462 |
EU |
40 | 1 |
Pertussis, Viral infection, Antibiotic therapy, Arthralgia, Diarrhoea, Influenza, |
||||
INFLIXIMAB, |
||||
| 529 | 26465547 |
75 | ||
Rash, Erythema, Pruritus, Skin burning sensation, Influenza, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 530 | 26465657 |
CA |
65 | 2 |
Adjustment disorder, Vomiting, Sneezing, Skin haemorrhage, Skin exfoliation, Sinusitis, Gangrene, Fatigue, Fall, Eating disorder, Dysphagia, Dysarthria, Cystitis, Cough, Coordination abnormal, Confusional state, Chest discomfort, Cerebrovascular accident, Cataract, Carotid artery thrombosis, Blood pressure increased, Arthritis, Arterial occlusive disease, Aphasia, Anxiety, Angina pectoris, Affect lability, Gastrointestinal disorder, Headache, Hemiplegia, Sinus disorder, Sinus congestion, Sensory loss, Rhinorrhoea, Rheumatoid arthritis, Respiratory tract congestion, Pyrexia, Psoriasis, Pneumonia, Personality disorder, Palpitations, Pain, Neurologic neglect syndrome, Nausea, Nasopharyngitis, Muscular weakness, Muscle spasticity, Motor dysfunction, Malaise, Influenza like illness, Influenza, Hemiparesis, Asthenia, Product use issue, |
||||
DIMENHYDRINATE, DIMENHYDRINATE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LISINOPRIL, ATORVASTATIN CALCIUM, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, SITAGLIPTIN, IRBESARTAN, IRBESARTAN, METHOTREXATE, METHOTREXATE SODIUM, ZOLPIDEM TARTRATE, LEVOTHYROXINE SODIUM, IRBESARTAN, IRBESARTAN, IRBESARTAN, RITUXIMAB, RITUXIMAB, PROCHLORPERAZINE, PREDNISONE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, MORPHINE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, CANDESARTAN, CALCIUM CARBONATE, ANTACID, BISOPROLOL FUMARATE, CANDESARTAN CILEXETIL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, AMLODIPINE, ALISKIREN HEMIFUMARATE, ALISKIREN HEMIFUMARATE, ALISKIREN HEMIFUMARATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, ERGOCALCIFEROL, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, PREGABALIN, INSULIN DETEMIR, INSULIN GLARGINE, HYDROCHLOROTHIAZIDE, INSULIN LISPRO, ZOLPIDEM TARTRATE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, TELMISARTAN, LEVOTHYROXINE SODIUM, USTEKINUMAB, ROSUVASTATIN, PANTOPRAZOLE, EZETIMIBE, COAL TAR, IRBESARTAN, AMLODIPINE BESYLATE, ACITRETIN, DULOXETINE HYDROCHLORIDE, CYANOCOBALAMIN, METHYLPREDNISOLONE ACETATE, CANDESARTAN CILEXETIL, METHOTREXATE SODIUM, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE, ESOMEPRAZOLE MAGNESIUM DIHYDRATE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, METHYLPREDNISOLONE, MORPHINE SULFATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, RAMIPRIL, LISINOPRIL, NAPROXEN, NAPROXEN SODIUM, VITAMIN C, ZOLPIDEM TARTRATE, ROSUVASTATIN CALCIUM, CANDESARTAN CILEXETIL, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, ESOMEPRAZOLE MAGNESIUM, ONDANSETRON HYDROCHLORIDE, PREDNISOLONE SODIUM PHOSPHATE, BISOPROLOL FUMARATE, METHYLPREDNISOLONE ACETATE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, PREDNISONE, AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, BISOPROLOL FUMARATE, IRBESARTAN, IRBESARTAN, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 531 | 26465687 |
CA |
68 | 2 |
Pneumonia, COVID-19, Influenza, Diarrhoea, Decreased appetite, |
||||
NINTEDANIB, |
||||
| 532 | 26465823 |
|||
Pain, Musculoskeletal stiffness, Influenza, |
||||
CERTOLIZUMAB PEGOL, ERGOCALCIFEROL, FISH OIL, |
||||
| 533 | 26465878 |
EU |
||
Asthenia, Gastrointestinal pain, Fatigue, Infection, Influenza, Therapy partial responder, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, ADALIMUMAB-AATY, HYDROCORTISONE, |
||||
| 534 | 26465890 |
EU |
68 | 2 |
Coronavirus infection, Influenza, Skin cancer, |
||||
UPADACITINIB, |
||||
| 535 | 26466614 |
US |
73 | 1 |
Influenza, Pneumonia, |
||||
POMALIDOMIDE, |
||||
| 536 | 26466635 |
US |
37 | 2 |
Surgery, Influenza, Therapeutic procedure, Weight decreased, Blood potassium decreased, Product dose omission issue, Underdose, |
||||
CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, MODAFINIL, |
||||
| 537 | 26467338 |
US |
1 | |
Contusion, Pruritus, Feeling hot, Influenza, Erythema, Hypokinesia, |
||||
RAVULIZUMAB, |
||||
| 538 | 26467515 |
US |
61 | 2 |
Insurance issue, Influenza, Ill-defined disorder, Headache, Tremor, Upper respiratory tract infection, Product use issue, Insurance issue, Malaise, |
||||
| 539 | 26467734 |
US |
1 | |
Influenza, Hallucination, Agitation, Vomiting, Cognitive disorder, Snoring, Dissociation, Thinking abnormal, Injury, Therapeutic response unexpected, Product administration interrupted, |
||||
SODIUM OXYBATE, SODIUM OXYBATE, MODAFINIL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, SERTRALINE HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, EZETIMIBE, CYCLOBENZAPRINE, CYCLOBENZAPRINE, HYDROXYZINE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, TIOTROPIUM BROMIDE, ALBUTEROL SULFATE, |
||||
| 540 | 26467820 |
US |
77 | 2 |
Choking, Knee arthroplasty, Macular degeneration, Superficial injury of eye, Fatigue, Sarcoidosis, Musculoskeletal stiffness, Stress, Memory impairment, Dysphagia, Cough, Astigmatism, Paranoia, Dizziness, Walking aid user, Anxiety, Language disorder, Eyelid function disorder, Psoriasis, Photosensitivity reaction, Contusion, Asthenia, Asthenopia, Sinusitis, Influenza, Headache, Pain, Nasopharyngitis, Amnesia, Pharyngitis, Corneal abrasion, Therapeutic response decreased, |
||||
NIPOCALIMAB, |
||||
| 541 | 26467902 |
22 | 2 | |
Limb injury, Localised infection, Limb injury, Wrong technique in product usage process, Product storage error, Product preparation error, Limb injury, Increased appetite, Limb injury, Acrochordon, Blister, Waist circumference decreased, Hepatomegaly, Acanthosis nigricans, Decreased appetite, Anaemia, Blood glucose abnormal, Blood glucose abnormal, Glycosylated haemoglobin increased, Influenza, Pyrexia, Weight increased, Pain in extremity, Heavy menstrual bleeding, Blood triglycerides increased, Nausea, |
||||
METRELEPTIN, METRELEPTIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ERGOCALCIFEROL, LOSARTAN, |
||||
| 542 | 26467944 |
US |
2 | |
Pulmonary fibrosis, Influenza, Pulmonary congestion, |
||||
UPADACITINIB, |
||||
| 543 | 26468100 |
EU |
79 | 1 |
Influenza, |
||||
BORTEZOMIB, DARATUMUMAB, |
||||
| 544 | 26468170 |
US |
66 | 2 |
Influenza, |
||||
TEZEPELUMAB-EKKO, TEZEPELUMAB-EKKO, |
||||
| 545 | 26468237 |
CA |
42 | 2 |
Pneumonia, Nasopharyngitis, Influenza, |
||||
EPTINEZUMAB-JJMR, ATORVASTATIN CALCIUM, |
||||
| 546 | 26468478 |
US |
2 | |
Influenza, Pneumonia, |
||||
INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, ERGOCALCIFEROL, OLANZAPINE, OLANZAPINE PAMOATE, PANTOPRAZOLE SODIUM, SERTRALINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE, ZOLPIDEM TARTRATE, DONEPEZIL HYDROCHLORIDE, |
||||
| 547 | 26468704 |
US |
29 | 2 |
Extra dose administered, Influenza, Vomiting, Nausea, |
||||
TIRZEPATIDE, |
||||
| 548 | 26468789 |
BR |
11 | 2 |
Viral infection, Influenza, |
||||
TALIGLUCERASE ALFA, TALIGLUCERASE ALFA, |
||||
| 549 | 26468962 |
65 | 2 | |
Influenza, Constipation, Vomiting, |
||||
LENALIDOMIDE, |
||||
| 550 | 26469026 |
US |
||
Influenza, |
||||
SELINEXOR, GLIPIZIDE, GLIPIZIDE-TABLETS, HYDROCHLOROTHIAZIDE, NAPROXEN, NAPROXEN SODIUM, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, POMALIDOMIDE, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, ALBUTEROL SULFATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, SULFAMETHOXAZOLE AND TRIMETHOPRIM, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 551 | 26469173 |
|||
Influenza, Dehydration, |
||||
VEDOLIZUMAB, |
||||
| 552 | 26469360 |
91 | ||
Dyspnoea, Angina pectoris, Vomiting, Limb injury, Malaise, Dizziness, Wheezing, Blood pressure increased, Drug ineffective, Influenza, |
||||
ZILUCOPLAN, PANTOPRAZOLE, PREDNISONE, |
||||
| 553 | 26469414 |
AU |
37 | 2 |
Thyroid mass, Influenza, Thyroid cancer, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 554 | 26469554 |
34 | ||
Maternal exposure before pregnancy, Maternal exposure during pregnancy, Caesarean section, Respiratory tract infection, Pyrexia, Nasopharyngitis, Influenza, Urinary tract infection, |
||||
CERTOLIZUMAB PEGOL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE, CAFFEINE, CAFFEINE, CEFDINIR, LORATADINE, LORATADINE TABLET, CLINDAMYCIN PHOSPHATE, CLINDAMYCIN, FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, LABETALOL, LABETALOL, LABETALOL, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PROGESTERONE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 555 | 26469761 |
US |
60 | 2 |
Influenza, Urinary tract infection, Nephrolithiasis, Breast cancer, Nausea, Vomiting, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 556 | 26469813 |
EU |
34 | |
Influenza, Febrile neutropenia, Thrombocytopenia, |
||||
SACITUZUMAB GOVITECAN, |
||||
| 557 | 26469867 |
US |
2 | |
Influenza, |
||||
TREPROSTINIL, TREPROSTINIL, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, AMOXICILLIN, ACETAMINOPHEN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, TOCILIZUMAB, OXYGEN, 0XYGEN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, MAGNESIUM, |
||||
| 558 | 26460782 |
66 | ||
Walking disability, Visual impairment, Eye discharge, Dry eye, Influenza, Peripheral swelling, Off label use, Insurance issue, Therapy interrupted, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, LEFLUNOMIDE, DEFLAZACORT, |
||||
| 559 | 26460960 |
JP |
83 | |
Influenza, Wrong technique in product usage process, |
||||
ROTIGOTINE, ROTIGOTINE, |
||||
| 560 | 26461199 |
US |
||
Influenza, |
||||
LENALIDOMIDE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, INSULIN ASPART, BORTEZOMIB, METOLAZONE, ONDANSETRON HYDROCHLORIDE, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, INSULIN GLARGINE, DARATUMUMAB AND HYALURONIDASE-FIHJ (HUMAN RECOMBINANT), ERYTHROPOIETIN, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 561 | 26461214 |
CA |
32 | 2 |
Bacterial infection, Forced expiratory volume decreased, Influenza, Musculoskeletal chest pain, Fungal infection, Obstructive airways disorder, Pneumonia, Tachycardia, Urticaria, Vomiting, Blood pressure increased, Decreased activity, Nasal congestion, Pain, Productive cough, Rales, Upper-airway cough syndrome, Vertigo, Dizziness, Psoriasis, Rhinitis, Terminal insomnia, Therapeutic product effect decreased, Therapeutic response decreased, Cough, Diarrhoea, Emphysema, Malaise, Nasal discharge discolouration, Urinary tract infection, Wheezing, Abdominal pain, Asthma, Dyspnoea exertional, Eczema, Feeding disorder, Full blood count abnormal, Oropharyngeal pain, Sleep disorder, Sleep disorder due to a general medical condition, Ear infection, Middle insomnia, Migraine, Nasopharyngitis, Restrictive pulmonary disease, Sinusitis, Stress, Anxiety, Drug ineffective, Dyspnoea, Eosinophil count abnormal, Heart rate increased, Infection, Product administration error, Tooth abscess, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, MONTELUKAST SODIUM, MONTELUKAST, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, IPRATROPIUM BROMIDE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, MEPOLIZUMAB, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, OMALIZUMAB, ALBUTEROL SULFATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, TERBUTALINE SULFATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, AMLODIPINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, EPINEPHRINE, CICLESONIDE, SEMAGLUTIDE, MONTELUKAST SODIUM, ALBUTEROL SULFATE, ALBUTEROL SULFATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, |
||||
| 562 | 26461359 |
US |
74 | 1 |
Influenza, Nausea, Anxiety, Depression, |
||||
ESCITALOPRAM, |
||||
| 563 | 26461572 |
US |
||
Influenza, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 564 | 26461633 |
60 | ||
Seasonal allergy, Influenza, |
||||
BIMEKIZUMAB, |
||||
| 565 | 26461649 |
US |
||
Influenza, |
||||
GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, |
||||
| 566 | 26461742 |
US |
2 | |
Immune system disorder, Pain, Influenza, |
||||
RISANKIZUMAB-RZAA, |
||||
| 567 | 26461875 |
US |
76 | 2 |
Influenza, |
||||
RIPRETINIB, |
||||
| 568 | 26462556 |
US |
2 | |
Renal impairment, Cardiac dysfunction, Illness, Malaise, Viral infection, Influenza, Blood cholesterol abnormal, |
||||
INCLISIRAN, |
||||
| 569 | 26462764 |
CA |
53 | |
Back pain, Contusion, Cough, Diarrhoea, Dry eye, Ear infection, Fatigue, Heart rate increased, Hypoacusis, Lower respiratory tract infection, Migraine, Nasal congestion, Oral herpes, Oropharyngeal pain, Pyrexia, Respiratory tract congestion, Rhinorrhoea, Sunburn, Urticaria, Weight decreased, Weight increased, Drug hypersensitivity, Influenza, Injection site bruising, Illness, Nasopharyngitis, Inappropriate schedule of product administration, Incorrect dose administered, Intentional product use issue, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, BACLOFEN, CARBAMAZEPINE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CLARITHROMYCIN, CLONAZEPAM, VANCOMYCIN HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE, PREDNISONE, |
||||
| 570 | 26463308 |
US |
64 | 2 |
Influenza, |
||||
TIRZEPATIDE, |
||||
| 571 | 26463497 |
US |
2 | |
Influenza, Nasopharyngitis, |
||||
TIRZEPATIDE, |
||||
| 572 | 26463650 |
86 | 2 | |
Influenza, Blood potassium abnormal, |
||||
LENALIDOMIDE, |
||||
| 573 | 26463694 |
CA |
2 | |
Immunodeficiency, Dyspnoea, Influenza, Exposure to communicable disease, Product use issue, |
||||
INFLIXIMAB, PROPRANOLOL HYDROCHLORIDE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 574 | 26463747 |
CN |
||
Death, Adverse event, Viral pericarditis, Tracheomalacia, Angioimmunoblastic T-cell lymphoma, Spontaneous bacterial peritonitis, Renal cancer metastatic, Nasopharyngeal cancer, Pemphigoid, Malignant melanoma, B-cell lymphoma, Dermatitis exfoliative, Dilated cardiomyopathy, Myelitis transverse, Lower respiratory tract infection, Pneumonia, Disability, Hospitalisation, Injection site haemorrhage, Cellulitis, Product dose omission issue, Accidental exposure to product, Parapsoriasis, Injection site plaque, Mycobacterium tuberculosis complex test positive, Eczema nummular, Nail pitting, Latent tuberculosis, Fibroadenoma of breast, Administration site reaction, Antinuclear antibody increased, Underdose, Product storage error, Dactylitis, Therapeutic product effect decreased, Inappropriate schedule of product administration, COVID-19, Influenza, |
||||
GUSELKUMAB, GUSELKUMAB, GUSELKUMAB, GUSELKUMAB, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LISINOPRIL, AMLODIPINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 575 | 26463840 |
|||
Sinusitis, Influenza, |
||||
BIMEKIZUMAB, FEXOFENADINE HYDROCHLORIDE, ERGOCALCIFEROL, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 576 | 26463853 |
CA |
75 | 2 |
Crohn^s disease, Illness, Rash macular, Influenza, |
||||
ZOLEDRONIC ACID, ZOLEDRONIC ACID, |
||||
| 577 | 26464044 |
US |
78 | 2 |
Disease complication, Thrombosis, Influenza, Incorrect dose administered by device, Injection site pain, Injection site haemorrhage, |
||||
EVOLOCUMAB, |
||||
| 578 | 26464137 |
EU |
65 | 1 |
Influenza, General physical health deterioration, Enteral nutrition, |
||||
EMPAGLIFLOZIN, ROTIGOTINE, CARBIDOPA AND LEVODOPA, PRUCALOPRIDE, MAGNESIUM, TORSEMIDE, FOLIC ACID, AMLODIPINE, RAMIPRIL, CLOZAPINE, OLANZAPINE, MIRTAZAPINE, |
||||
| 579 | 26464141 |
CA |
61 | 2 |
Affect lability, Angina pectoris, Aphasia, Arterial occlusive disease, Arthritis, Asthenia, Blood pressure increased, Carotid artery thrombosis, Cataract, Cerebrovascular accident, Chest discomfort, Confusional state, Coordination abnormal, Cough, Cystitis, Dysarthria, Dysphagia, Eating disorder, Gangrene, Gastrointestinal disorder, Headache, Hemiparesis, Hemiplegia, Influenza, Influenza like illness, Malaise, Motor dysfunction, Muscle spasticity, Muscular weakness, Nasopharyngitis, Neurologic neglect syndrome, Palpitations, Personality disorder, Pneumonia, Psoriasis, Pyrexia, Pain, Respiratory tract congestion, Rheumatoid arthritis, Rhinorrhoea, Sensory loss, Sinus congestion, Sinus disorder, Sinusitis, Skin exfoliation, Skin haemorrhage, Sneezing, Adjustment disorder, Gastrointestinal disorder, Fatigue, Anxiety, Vomiting, Fall, Nausea, |
||||
DIMENHYDRINATE, DIMENHYDRINATE, DIMENHYDRINATE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIMENHYDRINATE, DIMENHYDRINATE, ALISKIREN HEMIFUMARATE, ALISKIREN HEMIFUMARATE, ALISKIREN HEMIFUMARATE, AMLODIPINE BESYLATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, CALCIUM CARBONATE, ANTACID, CANDESARTAN, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, ERGOCALCIFEROL, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE, ESOMEPRAZOLE MAGNESIUM DIHYDRATE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE, ESOMEPRAZOLE MAGNESIUM DIHYDRATE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE, ESOMEPRAZOLE MAGNESIUM DIHYDRATE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE, ESOMEPRAZOLE MAGNESIUM DIHYDRATE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, IRBESARTAN, IRBESARTAN, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, LISINOPRIL, LISINOPRIL, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MORPHINE SULFATE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, PREDNISONE, PROCHLORPERAZINE, RITUXIMAB, RITUXIMAB, RITUXIMAB, PROCHLORPERAZINE, LEVOTHYROXINE SODIUM, ESOMEPRAZOLE SODIUM, ESOMEPRAZOLE SODIUM, ALISKIREN, ALISKIREN HEMIFUMARATE, CANDESARTAN CILEXETIL, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, CANDESARTAN CILEXETIL, ONDANSETRON HYDROCHLORIDE, RAMIPRIL, SITAGLIPTIN PHOSPHATE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ACITRETIN, HYDROCHLOROTHIAZIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, IRBESARTAN, DULOXETINE HYDROCHLORIDE, METHYLPREDNISOLONE ACETATE, EZETIMIBE, INSULIN LISPRO, SITAGLIPTIN, SITAGLIPTIN, INSULIN GLARGINE, INSULIN DETEMIR, INSULIN DETEMIR, PREGABALIN, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ROSUVASTATIN CALCIUM, SITAGLIPTIN, USTEKINUMAB, TELMISARTAN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ZOLPIDEM TARTRATE, COAL TAR, METHYLPREDNISOLONE, PANTOPRAZOLE, PANTOPRAZOLE, PREDNISOLONE SODIUM PHOSPHATE, PROCHLORPERAZINE MALEATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, LISINOPRIL, CALCIUM CARBONATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, SITAGLIPTIN PHOSPHATE, ZOLPIDEM TARTRATE, ACITRETIN, CYANOCOBALAMIN, LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE ANHYDROUS, METHYLPREDNISOLONE ACETATE, ESOMEPRAZOLE MAGNESIUM, OMEPRAZOLE MAGNESIUM, VITAMIN C, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 580 | 26464154 |
US |
2 | |
Hydrocephalus, Influenza, COVID-19, SARS-CoV-2 test positive, Cough, Oropharyngeal pain, Upper-airway cough syndrome, Fatigue, Pain, Wrong technique in device usage process, Wrong technique in product usage process, |
||||
ALBUTEROL SULFATE, |
||||
| 581 | 26464522 |
CA |
53 | 2 |
Gastrointestinal disorder, Malaise, Inappropriate schedule of product administration, Influenza, Hypertension, Illness, |
||||
FREMANEZUMAB-VFRM, PROPRANOLOL HYDROCHLORIDE, GABAPENTIN, |
||||
| 582 | 26464786 |
US |
38 | 2 |
Rash, Pruritus, Influenza, |
||||
SELEXIPAG, |
||||
| 583 | 26464833 |
US |
2 | |
Influenza, Nasopharyngitis, Productive cough, |
||||
SAPROPTERIN DIHYDROCHLORIDE, |
||||
| 584 | 26467326 |
49 | 1 | |
Nasopharyngitis, Influenza, |
||||
IPTACOPAN, DULOXETINE HYDROCHLORIDE, PEGCETACOPLAN, FOLIC ACID, LISINOPRIL, PENICILLIN V POTASSIUM, |
||||
| 585 | 26457007 |
US |
76 | 2 |
Influenza, |
||||
LENALIDOMIDE, |
||||
| 586 | 26457020 |
42 | ||
Influenza, Diplopia, Eyelid ptosis, Product dose omission issue, Product dose omission in error, |
||||
ZILUCOPLAN, ZILUCOPLAN, ZILUCOPLAN, ZILUCOPLAN, ZILUCOPLAN, ZILUCOPLAN, ZILUCOPLAN, PYRIDOSTIGMINE BROMIDE ORAL, LISINOPRIL, PYRIDOSTIGMINE BROMIDE, |
||||
| 587 | 26457163 |
US |
58 | 2 |
Ear infection, Sinusitis, Influenza, Off label use, |
||||
LENALIDOMIDE, |
||||
| 588 | 26457191 |
US |
64 | 1 |
Influenza, |
||||
LENALIDOMIDE, |
||||
| 589 | 26457356 |
CA |
66 | |
Abdominal pain, Blood pressure systolic increased, Dizziness, Eye infection, Feeling abnormal, Haematochezia, Haemorrhage, Hyperhidrosis, Hypotension, Influenza, Loss of consciousness, Mucous stools, Product dose omission issue, Therapeutic reaction time decreased, Visual impairment, |
||||
ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, MESALAMINE, MESALAMINE, PREDNISONE, |
||||
| 590 | 26457428 |
CA |
47 | |
Blood immunoglobulin E increased, Blood pressure systolic increased, Choking sensation, Dry eye, Dry mouth, Dysphagia, Eye pruritus, Influenza, Weight increased, Hypersensitivity, Illness, Nausea, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, OXAZEPAM, MONTELUKAST SODIUM, TIOTROPIUM BROMIDE, LEVOTHYROXINE SODIUM, ALBUTEROL SULFATE, |
||||
| 591 | 26457441 |
US |
40 | 2 |
Influenza, Pneumonia, Injection site pain, Injection site reaction, |
||||
TIRZEPATIDE, |
||||
| 592 | 26457445 |
EU |
58 | 1 |
Pleuritic pain, Influenza, Chronic obstructive pulmonary disease, |
||||
UPADACITINIB, |
||||
| 593 | 26457689 |
US |
64 | 2 |
Influenza, |
||||
TIRZEPATIDE, |
||||
| 594 | 26457915 |
US |
1 | |
Sepsis, Bacterial infection, Pulmonary oedema, Cardiac failure, Back pain, Influenza, Pain, Chills, Cough, Heart rate increased, Arthralgia, |
||||
AMIFAMPRIDINE PHOSPHATE, AMIFAMPRIDINE PHOSPHATE, AMIFAMPRIDINE PHOSPHATE, AMIFAMPRIDINE PHOSPHATE, FOLIC ACID, FUROSEMIDE, LISINOPRIL, METHOTREXATE, METHOTREXATE SODIUM, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, PREGABALIN, |
||||
| 595 | 26457933 |
US |
7 | 2 |
Sepsis, Influenza, |
||||
TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, BUDESONIDE, FERROUS SULFATE, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, |
||||
| 596 | 26458352 |
CA |
2 | |
Influenza, Malaise, Infection, |
||||
BENRALIZUMAB, BENRALIZUMAB, BENRALIZUMAB, ALBUTEROL SULFATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, TIOTROPIUM BROMIDE INHALATION SPRAY, |
||||
| 597 | 26458919 |
US |
2 | |
Influenza, |
||||
| 598 | 26458991 |
CA |
27 | |
Chills, Cough, Drug hypersensitivity, Ear swelling, Exposure to SARS-CoV-2, Gait disturbance, Glaucoma, Influenza, Joint swelling, Nasopharyngitis, Ocular hyperaemia, Oedema peripheral, Peripheral swelling, Platelet count decreased, Pruritus, Pyrexia, Rash, Renal impairment, Throat tightness, Urticaria, Visual field defect, Visual impairment, Vomiting, White blood cell count decreased, Headache, Condition aggravated, Therapy partial responder, Drug ineffective, Inappropriate schedule of product administration, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, PREDNISONE, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, |
||||
| 599 | 26459104 |
US |
||
Influenza, |
||||
CILTACABTAGENE AUTOLEUCEL, |
||||
| 600 | 26459168 |
CA |
24 | 1 |
Colitis ulcerative, Abdominal pain upper, Therapeutic reaction time decreased, Burning sensation, Diarrhoea, Malaise, Acne, Rash, Headache, Influenza, |
||||
VEDOLIZUMAB, PREDNISONE, MESALAMINE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28